Bashan Dror - Insider Non-Derivative Transactions at Protalix BioTherapeutics, Inc. (PLX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 1, 2024, Bashan Dror's relationship to Protalix BioTherapeutics, Inc. (PLX) is Director,Officer (PRESIDENT AND CEO), and currently has 2,149,418 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PLX insiders.
Data Source: SEC.
Bashan Dror - Insider Non-Derivative Transactions of PLX Common Stock
Bashan Dror - Insider Non-Derivative Transactions at PLX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 2, 2024 | Acquisition -- (Common Stock) | 263960 | 0 | 2149418 |
| Oct 20, 2023 | P -- (Common Stock) | 48387 | 1.4 | 116387 |
| Oct 20, 2023 | P -- (Common Stock) | 16129 | 1.41 | 132516 |
| Aug 16, 2023 | Acquisition -- (Common Stock) | 800000 | 0 | 1885458 |